Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (421-430 of 941) with videos related to

Pageof 95
Sort By:
Journal of Experimental Botany|January 9, 2009
Gene expression studies in kiwifruit and gene over-expression in Arabidopsis indicates that GDP-L-galactose guanyltransferase is a major control point of vitamin C biosynthesisSean M Bulley, Maysoon Rassam, Dana Hoser, et al.
European Urology|August 21, 2013
Castration-resistant prostate cancer: from new pathophysiology to new treatmentSrikala S Sridhar, Stephen J Freedland, Martin E Gleave, et al.
Nature Communications|December 16, 2014
Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survivalFan Zhang, Masafumi Kumano, Eliana Beraldi, et al.
Gates Open Research|November 21, 2024
Power calculation for mosquito bioassays: Quantifying variability in the WHO tube bioassay and developing sample size guidance for the PBO synergism assay using a Shiny applicationFrank Mechan, Giorgio Praulins, Jack Gillespie, et al.
Chemmedchem|June 18, 2009
PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cellsXiao-Xuan Liu, Palma Rocchi, Fan-Qi Qu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2009
Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinomaElie Hadchity, Marie-Thérèse Aloy, Christian Paulin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2009
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitorsTao Liu, Pei Y Liu, Andrew E L Tee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2010
Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteersManoli Vourvahis, Michelle Gleave, Angus N R Nedderman, et al.
Molecular Cancer Research : MCR|October 12, 2011
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancerMasaki Shiota, Amina Zoubeidi, Masafumi Kumano, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 95

Showing results (421-430 of 941) with videos related to

Sort By:
Pageof 95
Journal of Experimental Botany|January 9, 2009
Gene expression studies in kiwifruit and gene over-expression in Arabidopsis indicates that GDP-L-galactose guanyltransferase is a major control point of vitamin C biosynthesisSean M Bulley, Maysoon Rassam, Dana Hoser, et al.
European Urology|August 21, 2013
Castration-resistant prostate cancer: from new pathophysiology to new treatmentSrikala S Sridhar, Stephen J Freedland, Martin E Gleave, et al.
Nature Communications|December 16, 2014
Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survivalFan Zhang, Masafumi Kumano, Eliana Beraldi, et al.
Gates Open Research|November 21, 2024
Power calculation for mosquito bioassays: Quantifying variability in the WHO tube bioassay and developing sample size guidance for the PBO synergism assay using a Shiny applicationFrank Mechan, Giorgio Praulins, Jack Gillespie, et al.
Chemmedchem|June 18, 2009
PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cellsXiao-Xuan Liu, Palma Rocchi, Fan-Qi Qu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 14, 2009
Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinomaElie Hadchity, Marie-Thérèse Aloy, Christian Paulin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2009
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitorsTao Liu, Pei Y Liu, Andrew E L Tee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2010
Excretion and metabolism of lersivirine (5-{[3,5-diethyl-1-(2-hydroxyethyl)(3,5-14C2)-1H-pyrazol-4-yl]oxy}benzene-1,3-dicarbonitrile), a next-generation non-nucleoside reverse transcriptase inhibitor, after administration of [14C]Lersivirine to healthy volunteersManoli Vourvahis, Michelle Gleave, Angus N R Nedderman, et al.
Molecular Cancer Research : MCR|October 12, 2011
Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancerMasaki Shiota, Amina Zoubeidi, Masafumi Kumano, et al.
The Prostate|January 4, 2012
TP53INP1 as new therapeutic target in castration-resistant prostate cancerSophie Giusiano, Virginie Baylot, Claudia Andrieu, et al.
Pageof 95